SEARCH

SEARCH BY CITATION

References

  • Biteau B., Labarre J. and Toledano M. B. (2003) ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425, 980984.
  • Boulos S., Meloni B. P., Arthur P. G., Bojarski C. and Knuckey N. W. (2007) Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury. J. Neurosci. Res. 85, 30893097.
  • Budanov A. V., Sablina A. A., Feinstein E., Koonin E. V. and Chumakov P. M. (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596600.
  • Chang T. S., Jeong W., Woo H. A., Lee S. M., Park S. and Rhee S. G. (2004) Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 5099451001.
  • Cho H. Y., Jedlicka A. E., Reddy S. P., Kensler T. W., Yamamoto M., Zhang L. Y. and Kleeberger S. R. (2002) Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26, 175182.
  • Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O’Connor T., Harada T. and Yamamoto M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169177.
  • Fang J., Nakamura T., Cho D. H., Gu Z. and Lipton S. A. (2007) S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson’s disease. Proc. Natl Acad. Sci. USA 104, 1874218747.
  • Giudice A. and Montella M. (2006) Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 28, 169181.
  • Hardingham G. E., Arnold F. J. and Bading H. (2001) Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat. Neurosci. 4, 261267.
  • Hardingham G. E., Fukunaga Y. and Bading H. (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405414.
  • Hattori F., Murayama N., Noshita T. and Oikawa S. (2003) Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 86, 860868.
  • Immenschuh S. and Baumgart-Vogt E. (2005) Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal. 7, 768777.
  • Jakel R. J., Townsend J. A., Kraft A. D. and Johnson J. A. (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res. 1144, 192201.
  • Jonsson T. J., Johnson L. C. and Lowther W. T. (2008) Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace. Nature 451, 98101.
  • Kotkow K. J. and Orkin S. H. (1995) Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15, 46404647.
  • Kraft A. D., Johnson D. A. and Johnson J. A. (2004) Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24, 11011112.
  • Lee J. M., Li J., Johnson D. A., Stein T. D., Kraft A. D., Calkins M. J., Jakel R. J. and Johnson J. A. (2005) Nrf2, a multi-organ protector? FASEB J. 19, 10611066.
  • Mckenzie G. J., Stephenson P., Ward G., Papadia S., Bading H., Chawla S., Privalsky M. and Hardingham G. E. (2005) Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J. Neurochem. 93, 171185.
  • McKenzie G., Ward G., Stallwood Y., Briend E., Papadia S., Lennard A., Turner M., Champion B. and Hardingham G. E. (2006) Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals. BMC Cell Biol. 7, 10.
  • McMahon M., Itoh K., Yamamoto M. and Hayes J. D. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278, 2159221600.
  • Nguyen T., Yang C. S. and Pickett C. B. (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic. Biol. Med. 37, 433441.
  • Nioi P., McMahon M., Itoh K., Yamamoto M. and Hayes J. D. (2003) Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 374, 337348.
  • Numazawa S., Ishikawa M., Yoshida A., Tanaka S. and Yoshida T. (2003) Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 285, C334C342.
  • Papadia S., Stevenson P., Hardingham N. R., Bading H. and Hardingham G. E. (2005) Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 42794287.
  • Papadia S., Soriano F. X., Leveille F. et al. (2008) Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476487.
  • Qu D., Rashidian J., Mount M. P. et al. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron 55, 3752.
  • Rhee S. G., Jeong W., Chang T. S. and Woo H. A. (2007) Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int. Suppl., 106, S3S8.
  • Sanchez-Font M. F., Sebastia J., Sanfeliu C., Cristofol R., Marfany G. and Gonzalez-Duarte R. (2003) Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell. Mol. Life Sci. 60, 15131523.
  • Satoh T., Okamoto S. I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K. and Lipton S. A. (2006) Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc. Natl Acad. Sci. USA 103, 768773.
  • Shih A. Y., Johnson D. A., Wong G., Kraft A. D., Jiang L., Erb H., Johnson J. A. and Murphy T. H. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 33943406.
  • Shih A. Y., Li P. and Murphy T. H. (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 25, 1032110335.
  • Stocker R. (2004) Antioxidant activities of bile pigments. Antioxid. Redox Signal. 6, 841849.
  • Sykiotis G. P. and Bohmann D. (2008) Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14, 7685.
  • Winyard P. G., Moody C. J. and Jacob C. (2005) Oxidative activation of antioxidant defence. Trends Biochem. Sci. 30, 453461.
  • Woo H. A., Jeong W., Chang T. S., Park K. J., Park S. J., Yang J. S. and Rhee S. G. (2005) Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J. Biol. Chem. 280, 31253128.
  • Wood Z. A., Schroder E., Robin Harris J. and Poole L. B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 3240.
  • Yao J., Taylor M., Davey F., Ren Y., Aiton J., Coote P., Fang F., Chen J. X., Yan S. D. and Gunn-Moore F. J. (2007) Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model. Mol. Cell. Neurosci. 35, 377382.
  • Yoshida T., Nakamura H., Masutani H. and Yodoi J. (2005) The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann. NY Acad. Sci. 1055, 112.
  • Zhang D. D. (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38, 769789.
  • Zhao J., Kobori N., Aronowski J. and Dash P. K. (2006) Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett. 393, 108112.